Preferred Label : Site&type override flag:Arb:Pt:Cancer case.XXX:Ord:;
LOINC status : ACTIVE;
LOINC long common name : Siteandtype override flag Cancer case;
LOINC short name : Site/type O/R Cancer case;
LOINC description : Some computer edits identify errors. Others indicate possible errors that require
manual review for resolution. To eliminate the need to review the same cases repeatedly,
over-ride flags have been developed to indicate that data in a record (or records)
have been reviewed and, while unusual, are correct. This over-ride is used with the
following edits in the NAACCR Metafile of the EDITS software: Primary Site, Morphology-Type
Check (SEER IF25) Primary Site, Morphology-Type Check ICDO3 (SEER IF25) Some edits
check for code combinations that are possible, but quite rare. If the code combination
generates an error message and review of the case indicates that the codes are correct
for the case then the over-ride flag is used to skip the edit in the future. See Chapter
IV, Recommended Data Edits and Software Coordination of Standards. Over-ride Flag
as Used in the EDITS Software Package Multiple versions of edits of the type Primary
site, Morphology-Type check for usual combinations of site and ICD-O-2 or ICD-O-3
histology. The SEER version of the edit is more restrictive than the COC edit, and
thus uses a different over-ride flag. The COC version of the edit will accept Over-ride
COC-Site/Type or Over-ride Site/Type as equivalent. The Site/Histology validation
list (available on the SEER web site) contains those histologies commonly found in
the specified primary site. Histologies that occur only rarely or never are not included.
These edits require review of all combinations not listed. Since basal and squamous
cell carcinomas of non-genital skin sites are not reportable to SEER, these site/histology
combinations do not appear on the SEER validation list. For the COC version of the
edit, if Primary Site is in the rage C440-C449 (skin), and Histologic Type ICD-O-3
is in the range 8000-8005 (neoplasms, malignant, NOS), 8010-8046 (epithelial carcinomas),
8050-8084 (papillary and squamous cell carcinomas), or 8090-8110 (basal cell carcinomas),
no further editing is done. No over-ride is necessary for these cases in the COC version
of the edit. Review of these cases requires investigating whether a) the combination
is biologically implausible, or b) there are cancer registry coding conventions that
would dictate different codes for the diagnosis. Review of these rare combinations
often results in changes to the primary site and/or morphology, rather than a decision
that the combination is correct. Instructions for Coding Leave blank if the program
does not generate an error message for the edit Primary Site, Morphology-Type Check
(SEER IF25) and/or the edit Primary Site, Morphology-Type ICDO3 (SEERIF25). Leave
blank and correct any errors for the case if an item is discovered to be incorrect.
Code 1 if the case has been reviewed and both the site and histology are correct...
NAACCR Data Standards and Data Dictionary Version 11;
Origin ID : 21995-6;
UMLS CUI : C0804782;
Has component
- Has property
- Has scale
- Has system
- Has time aspect
- Part of panel
- Semantic type(s)
